Scientists at Yale find approval not a guarantor of drug safety Researchers at the Yale School of Medicine have published a 2017 report showing that of 222 drugs the U.S. Food and Drug Administration (FDA) approved between 2001 and 2010, 71 were affected by safety events after they had already been sold to patients. Dr. Joseph Ross and his colleagues studied the FDA’s approval process for new drugs and found that the median time from the FDA’s approval of the...Continue Reading
Over 18,000 patients accuse Johnson & Johnson and Bayer of failing to inform doctors about the dangers of the blood-thinning drug. On April 24th, a bellwether trial began in the lawsuit against the stroke drug, Xarelto, manufactured by Johnson & Johnson and Bayer. The plaintiffs accuse the pharmaceutical companies of failing to provide sufficient information about the risks involved in taking Xarelto, including what the plaintiffs claim is a high chance for severe bleeding events. The Chicago Tribune reports that...Continue Reading
The Military Times recently reported on the case of Sgt. 1st Class Cameron Corder, a soldier who broke his back in a helicopter accident in Afghanistan in 2013. Corder, a Michigan native and army medic, was treating a Marine injured in an IED blast when his injury happened. The Marine that Corder was treating, likely suffering shock, became aggressive inside the helicopter and tackled Corder to the floor. Corder says that he fell into medical equipment inside the helicopter and...Continue Reading
The World Health Organization’s (WHO) International Agency for Research on Cancer (IARC) has been under fire lately after a controversial finding that the world’s leading herbicide, glyphosate, is “probably carcinogenic.” Criticism of the agency, including the charge that they are sometimes too hasty in concluding that a substance is carcinogenic, has led to some U.S. lawmakers calling into question the U.S. funding of the WHO program. Groups like CropLife America have been standard-bearers for criticism of the agency, alleging that...Continue Reading
The U.S. Environmental Protection Agency (EPA) had scheduled a panel to determine whether glyphosate, the chemical present in Monsanto’s Roundup line of products, is safe for use. These meetings, initially scheduled for October 18-21, have now been postponed. The EPA says these meetings were postponed to allow the inclusion of additional epidemiologists to better assess the chemical’s carcinogenicity and “allow for a more robust review of the data.” Several lawsuits have been filed regarding Monsanto’s line of Roundup Weed Killer...Continue Reading
Speak with a Lawyer
Contact an attorney today for a free and confidential legal consultation.